Oncology
Conference Coverage
Androgen receptor screening not ready for triple-negative breast cancer
LAS VEGAS – Screening for androgen receptors is currently encouraged only in the context of clinical trials for triple-negative breast cancer.
Conference Coverage
VIDEO: Dr. Lisa Newman on triple negative breast cancer in African American women
LAS VEGAS – The heavy burden of triple negative and other aggressive breast cancers among African American women cannot be simplified to...
Conference Coverage
BRCA2 mutations linked to greater risk for pancreatic cancer
MIAMI BEACH – A higher incidence of pancreatic abnormalities on imaging among BRCA2 mutation carriers may provide a potential screening target.
From the Journals
Racial differences in skin cancer risk after organ transplantation
Do dermatologists need to consider patients’ race when doing organ transplants?
Conference Coverage
VIDEO: HER2+ patients may do fine with local therapies alone
MIAMI BEACH – Unquestionably, the advent of human epidermal growth factor receptor-2 (HER2) inhibitors has dramatically improved long-term...
Conference Coverage
One-third of micropapillary thyroid cancer found to be multifocal
Micropapillary thyroid cancer is not always a benign diagnosis.
Conference Coverage
RNA-based biopsy test bests NCCN risk stratification for PC prognosis
ORLANDO – Can genomic testing at the diagnostic biopsy stage identify patients most likely to develop metastases from prostate cancer?
Conference Coverage
Study finds community-hospital lung cancer screening feasible
Implementing a lung cancer screening program in a community hospital setting is feasible and saves lives, but implementation comes with challenges...
From the Journals
Counsel women against unnecessary prophylactic mastectomies
Women with breast cancer are much less likely to opt for contralateral prophylactic mastectomies if they know it won’t prolong their lives,...
From the Journals
Skin cancer a concern in pediatric solid organ transplant recipients
As survival rates among pediatric organ transplant recipients grow, so do the rates of cutaneous malignancy later in life for this population, who...
Conference Coverage
Tumor boards linked to improved survival in hepatocellular carcinoma
BOSTON – Veterans were about 13% less likely to die within 5 years of hepatocellular carcinoma diagnosis when multidisciplinary tumor boards...